Entelo bio is a computational biotech company building the engine for functional cell profiling and novel target discovery.
Entelo Bio has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in April 2026.
Entelo Bio's investors include Ananda Impact Ventures, Creator Fund.
Entelo Bio is headquartered in Oxford, United Kingdom.
Entelo bio is a computational biotech company building the engine for functional cell profiling and novel target discovery.
Entelo Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Entelo Bio — Funding & Investors." VCBacked, April 24, 2026, https://www.vcbacked.co/company/entelo-bio. Accessed August 14, 2026.
VCBacked. (2026). Entelo Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/entelo-bio
{{cite web |title=Entelo Bio — Funding & Investors |url=https://www.vcbacked.co/company/entelo-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated